Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Response Aid (GRA) is a Dubai-based healthcare solutions provider established to address public health challenges, specifically focusing on the procurement and distribution of medical supplies and pharmaceuticals during global health crises. The company gained significant prominence during the COVID-19 pandemic through its partnership with Dr. Reddy's Laboratories to manufacture and distribute Avigan (favipiravir) globally. GRA works with a network of manufacturers to provide access to antiviral treatments, diagnostic kits, and personal protective equipment. Their business model focuses on rapid response logistics and regulatory navigation to ensure the availability of critical medicines in underserved markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on G Response Aid.